Twin Tree Management’s Edwards Lifesciences EW Stock Holding History

Twin Tree Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92M	Sell	24,000 -225,500	-90%	-$18.6M	0.04%	498
2025 Q4	$21.3M	Sell	249,500 -170,800	-41%	-$14M	0.19%	123
2025 Q3	$32.7M	Buy	420,300 +27,500	+7%	+$2.15M	0.14%	169
2025 Q2	$30.7M	Buy	392,800 +371,500	+1,744%	+$27.7M	0.06%	330
2025 Q1	$1.54M	Buy	+21,300	New	+$1.52M	﹤0.01%	1195
2024 Q4	–	Sell	-60,200	Closed	-$3.97M	–	1668
2024 Q3	$3.97M	Sell	60,200 -231,200	-79%	-$16.8M	0.01%	968
2024 Q2	$26.9M	Sell	291,400 -249,200	-46%	-$22.1M	0.06%	293
2024 Q1	$51.7M	Buy	540,600 +487,600	+920%	+$41M	0.11%	174
2023 Q4	$4.04M	Sell	53,000 -25,300	-32%	-$1.76M	0.01%	928
2023 Q3	$5.42M	Buy	+78,300	New	+$6.29M	0.01%	659
2023 Q1	–	Sell	-10,300	Closed	-$768K	–	1370
2022 Q4	$768K	Sell	10,300 -49,900	-83%	-$3.85M	﹤0.01%	1059
2022 Q3	$4.97M	Sell	60,200 -59,300	-50%	-$5.71M	0.01%	763
2022 Q2	$11.4M	Buy	+119,500	New	+$12.4M	0.02%	606
2022 Q1	–	Sell	-185,400	Closed	-$24M	–	1702
2021 Q4	$24M	Buy	+185,400	New	+$21.6M	0.05%	356
2020 Q3	–	Sell	-273,700	Closed	-$18.9M	–	1334
2020 Q2	$18.9M	Buy	+273,700	New	+$19.5M	0.08%	288
2020 Q1	–	Sell	-25,500	Closed	-$1.98M	–	1426
2019 Q4	$1.98M	Sell	25,500 -133,200	-84%	-$10.4M	0.01%	725
2019 Q3	$11.6M	Sell	158,700 -168,300	-51%	-$11.8M	0.05%	281
2019 Q2	$20.1M	Buy	327,000 +244,200	+295%	+$14.8M	0.1%	184
2019 Q1	$5.28M	Buy	+82,800	New	+$4.73M	0.03%	427
2018 Q2	–	Sell	-1,200	Closed	-$56K	–	1189
2018 Q1	$56K	Buy	1,200 +900	+300%	+$39.1K	﹤0.01%	998
2017 Q4	$11K	Buy	+300	New	+$11K	﹤0.01%	963
2017 Q3	–	Sell	-3,900	Closed	-$154K	–	1030
2017 Q2	$154K	Buy	+3,900	New	+$142K	﹤0.01%	829
2016 Q2	–	Sell	-28,800	Closed	-$847K	–	1255
2016 Q1	$847K	Buy	28,800 +13,800	+92%	+$381K	0.02%	662
2015 Q4	$395K	Buy	+15,000	New	+$390K	0.01%	929
2015 Q2	–	Sell	-76,200	Closed	-$1.81M	–	1362
2015 Q1	$1.81M	Buy	76,200 +64,800	+568%	+$1.45M	0.05%	411
2014 Q4	$242K	Buy	+11,400	New	+$229K	0.01%	883
2013 Q3	–	Sell	-49,200	Closed	-$551K	–	838
2013 Q2	$551K	Buy	+49,200	New	+$582K	0.02%	580

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Twin Tree Management's EW Position: Q2 2025 in Review

Twin Tree Management sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 94,106 shares — an estimated $7.02M sold.

Twin Tree Management first reported a position in EW in Q2 2013 and held it in 35 quarters. The position peaked at $40.9M in Q2 2022. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2025.

Twin Tree Management reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
Twin Tree Management sold 94,106 Edwards Lifesciences shares in Q2 2025, an estimated $7.02M.
Twin Tree Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 35 quarters.
Twin Tree Management's Edwards Lifesciences position peaked at $40.9M in Q2 2022.
1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.